Haemonetics swings to Q1 red, lowers full-year guidance; Wall Street flees

Mon, 07/29/2013 - 12:39pm
Mass Device

Haemonetics takes a hard dive on Wall Street after posting lackluster Q1 financial results and lowering its full-year 2014 expectations.

Haemonetics slips to red in Q1 2014

Haemonetics Corp. (NYSE:HAE) took a Wall Street dip after posting a hard swing to the red and adjusted per-share earnings just shy of analysts' expectations.

Braintree, Mass.-based Haemonetics missed per-share analyst estimates by 1 penny and posted a nearly full reversal of the profits reported for this quarter last year, despite a 24% jump in sales. Wall Street responded by sending shares down nearly 9% by about 12:30 p.m. today.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.